# Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Review · Michael Albrecht Nauck, Juris Jendrik Meier, Matthew Aaron Cavender, Mirna S. Abd El Aziz, Daniel J. Drucker

- Archive id: doi:10.1161/circulationaha.117.028136
- Published: 2017-08-28
- Venue: Circulation
- DOI: https://doi.org/10.1161/circulationaha.117.028136
- PMID: 28847797
- Citations: 581
- Source URL: https://doi.org/10.1161/circulationaha.117.028136
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.